about
MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikisCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesOvercome support vector machine diagnosis overfittingp53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cellsNVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent mannerThe Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer riskSilencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuliAlpha cyano-4-hydroxy-3-methoxycinnamic acid inhibits proliferation and induces apoptosis in human breast cancer cellsPrepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary glandSingle cell resolution in vivo imaging of DNA damage following PARP inhibitionUrsolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells.Mutations in p53, p53 protein overexpression and breast cancer survivalAssociations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumorsDisruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapyMulti-resolution independent component analysis for high-performance tumor classification and biomarker discovery.Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells.Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cellsTargeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumorsComputational analyses of curcuminoid analogs against kinase domain of HER2Histopathology and Prognostic Indices of Carcinoma Breast with Special Reference to p53 MarkerPleomorphic carcinoma of breast: a case report and review of literatureHeat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis.Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse modelERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.Phytochemical-induced nucleolar stress results in the inhibition of breast cancer cell proliferation.A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsA p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferationTP53 status and response to treatment in breast cancersp53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.Regulation of p53 level by UBE4B in breast cancer.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.
P2860
Q24314897-2EF56283-7FF9-4525-A27E-0E0876B92830Q26743510-A9BB6982-A07B-44D5-8AC8-CBC566AF8C2BQ28082900-7FF16640-D0D7-4BC0-A68B-95F39BE2015FQ28259090-10B61BBE-5A18-4B5C-84E8-F40C366D08B8Q28483767-680798E8-BDAA-462B-B4B3-99A322682486Q28484331-90744959-F07E-4D5D-B31B-0F698595A733Q28484842-07C6ADCB-9138-4CA2-941A-AD5B83D6ECDDQ28536827-59EAF9E5-4041-467A-865A-AEFD1AC034B6Q28573752-EF806513-E2A6-4F1E-83C8-2A879B24BFC5Q30650918-1A313047-5ACC-464C-98FE-CE24E1AABAA4Q33592858-B8489743-1EC1-4121-897B-5BA0CAF7E59AQ33703486-FFCC57D4-50EA-40A0-9805-20F0C4A0DD30Q33789777-6F5C45B0-B4BE-4AA4-9D4C-BC7D4F371ED9Q33789802-E7898238-EA3B-4D28-8464-6A1CA2FE43BFQ33827076-FFC28602-1B2E-4B87-95CF-F66688590FF6Q33857846-4B9103AA-1A8E-42F4-AC96-953FBD412386Q33903965-F9A31691-A432-4BC8-95AC-E70D543A78F3Q33921638-B72337EF-6C01-4706-AAA2-3A56DB6044E2Q34005315-80DA29B8-D8DA-4B6F-ADCF-8C63A98ADEECQ34042070-8EA51977-7A59-4199-B5E7-21F9691E522EQ34047882-650E0BF0-872A-41A5-9C8C-154B886B1E69Q34084939-3DDB795E-05AC-488F-A101-C41FDA2D19B4Q34108330-C1C44B06-67EB-4228-B236-4732982CFFD4Q34121623-E2BF388F-A72E-4A70-AB6A-E695A71013AEQ34134476-6D6E7221-74C5-4DA7-B671-59B6603888EAQ34155238-CA1AD128-1988-4EF0-B252-ED6AB4A607D1Q34294432-F48A2BBE-9881-4FF9-A9EC-6F4BB512C88CQ34298885-5E5532F5-001C-42AD-A7FE-D9D90EE29C40Q34483120-C57E4294-4F4C-4612-8B8A-622936F08240Q34553965-F5E54FC7-C9D1-4A50-9594-6908E4C97A55Q34577709-362AB705-19CC-40EC-A4EB-A1460405DDD0Q34674316-998539C5-7B2F-4C13-94DA-6AA264B3825AQ34825969-8A4BB594-FEE0-443F-8892-D865E94000AFQ34956879-C65B8701-C9E6-49A0-9E82-00EEB76D0A90Q35029505-68B4B8CA-A255-4752-94DA-9C759B210B12Q35043933-DCFCF208-59DB-48F9-9BD4-7729017BC8B2Q35051755-D2BE06FB-AC65-4F54-9CD8-C8165926F210Q35065451-84AA498C-C048-4E12-8EC3-9397142593BBQ35108767-C5DA1CD0-5C79-4E7A-9C96-3D7C3666B57AQ35157919-263E98F9-14B4-4B8E-A544-73D46EF6B379
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
p53 and breast cancer, an update
@ast
p53 and breast cancer, an update
@en
p53 and breast cancer, an update
@nl
type
label
p53 and breast cancer, an update
@ast
p53 and breast cancer, an update
@en
p53 and breast cancer, an update
@nl
prefLabel
p53 and breast cancer, an update
@ast
p53 and breast cancer, an update
@en
p53 and breast cancer, an update
@nl
P2093
P3181
P356
P1476
p53 and breast cancer, an update
@en
P2093
Guy Leclercq
Marc Lacroix
Robert-Alain Toillon
P304
P3181
P356
10.1677/ERC.1.01172
P407
P577
2006-06-01T00:00:00Z